Methylprednisolone versus intravenous immunoglobulins in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): an open-label, multicentre, randomised trial

DSpace Repository

Methylprednisolone versus intravenous immunoglobulins in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): an open-label, multicentre, randomised trial

Author: Welzel, Tatjana; Atkinson, Andrew; Schobi, Nina; Andre, Maya C.; Bailey, Douggl G. N.; Blanchard-Rohner, Geraldine; Buettcher, Michael; Grazioli, Serge; Koehler, Henrik; Perez, Marie-Helene; Truck, Johannes; Vanoni, Federica; Zimmermann, Petra; Sanchez, Carlos; Bielicki, Julia A.; Schlapbach, Luregn J.
Tübinger Autor(en):
André, Maya C.
Published in: Lancet Child & Adolescent Health (2023), Bd. 7, H. 4, S. 238-248
Verlagsangabe: Elsevier Sci Ltd
Language: English
Full text: http://dx.doi.org/10.1016/S2352-4642(23)00020-2
ISSN: 2352-4642
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)